Coronary Artery Disease and Revascularization in Patients Undergoing Transcatheter Aortic Valve Replacement

Aakash Garg1, Suleman Ilyas1, Michael Cryer2

  • 1Division of Cardiology, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Insights

Coronary artery disease (CAD) is common in patients undergoing transcatheter aortic valve replacement (TAVR). Optimal management of CAD before and after TAVR requires further research to improve patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Coronary artery disease (CAD) and aortic stenosis share common risk factors and pathophysiology.
  • CAD is prevalent in up to 50% of patients evaluated for aortic valve replacement, impacting outcomes.

Purpose of the Study:

  • To review current literature on CAD in patients undergoing transcatheter aortic valve replacement (TAVR).
  • To focus on CAD prevalence, impact on outcomes, revascularization timing, and post-TAVR coronary intervention challenges.

Main Methods:

  • Systematic literature review of studies on CAD in TAVR patients.
  • Analysis of data regarding pre-TAVR CAD evaluation and revascularization strategies.
  • Examination of outcomes and feasibility of coronary interventions after TAVR.

Main Results:

  • CAD significantly affects outcomes in TAVR patients, particularly with severe disease.
  • Optimal timing and indications for revascularization in TAVR patients remain under investigation.
  • Limited data exists on the incidence, feasibility, and outcomes of percutaneous coronary intervention (PCI) post-TAVR.

Conclusions:

  • The management of CAD in the expanding TAVR population requires further clarification.
  • More research is needed on pre-TAVR CAD assessment and revascularization strategies.
  • Understanding post-TAVR coronary interventions is crucial for comprehensive patient care.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.4K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655